Looking to sell Paige stock or options?
Paige is the developer of a computational pathology module platform designed for swift diagnostic categorization and cancer detection. This platform utilizes a deep learning algorithm built on convolutional and recurrent neural networks, as well as generative models, with a focus on breast, prostate, and other major cancer types. It enables clinical researchers and pathologists to grasp the progression of diseases with various mutations, facilitating more efficient treatment.
Casdin Capital, Kenan Turnacioglu, HealthCare Ventures, AI Venture Labs, Kohlberg Kravis Roberts, Healthcare Venture Partners, Catalio Capital Management, Memorial Sloan Kettering Cancer Center, Palkon Capital Management, Breyer Capital, Goldman Sachs Asset Management, Johnson & Johnson Innovation - JJDC.